# Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium

> **NCT06624592** · PHASE3 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 400 (estimated)

## Conditions studied

- Delirium on Emergence

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Isoflurane

## Key facts

- **NCT ID:** NCT06624592
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06624592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06624592, "Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT06624592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*